Comparing TR Band to Statseal in Conjunction With TR Band II

Not Applicable

Terminated

Conditions: Arterial Occlusion
Hematoma
Coronary Artery Disease
Cardiovascular Diseases
Anticoagulant-induced Bleeding
Atherosclerosis

Brief Summary: The purpose of this clinical study is to compare how well two different devices for achieving hemostasis perform in patients undergoing transradial procedures. Both devices are approved by the FDA for this use, and have already been used by clinicians on patients undergoing transradial procedures. It is believed that the use of both devices in combination compared to the hemostasis band (TR band) alone will shorten the time that it takes to 'seal' the artery, resulting in a shorter period of time that you would need to wear the hemostasis band.

Detailed Description: This study is a physician initiated, prospective, observational, two arm, randomized study to be performed at experienced 'Radial First' centers. Patients having undergone successful radial catheterization will be enrolled in the study. Enrollment with continue at each site with an initial goal of 800 patients enrolled, with each center contributing a minimum of 50 patients. Study will be have a single interim analysis after 400 patients are enrolled for efficacy and safety and continuation of the study. Clinicians will perform the catheterization in accordance with local standard practice, with no minimum amount of anticoagulation required.

Unlike the pilot trial of this device, the present study will have an identical time to first deflation of 60 minutes between the two groups, and have a larger sample size to detect any excess risk of hematoma or radial artery occlusion. The study may also help demonstrate a relatively low rate of radial artery occlusion with a rapid deflation protocol, even at lower doses of unfractionated heparin than currently recommended.

Recruitment & Eligibility

Inclusion Criteria

Exclusion Criteria

any one of the following...

Use of a radial sheath larger than 6 Fr (a 7Fr-in-6 Glidesheath Slender ® is allowed).
Use of a hemostasis method or device besides the TR Band.
Patients undergoing catheterization from the femoral, brachial, ulnar, or distal radial (snuffbox) artery approach.
Use of an anticoagulant other than unfractionated heparin or bivalirudin.
Any use of glycoprotein inhibitors or cangrelor.
Use of sheathless guides.
Any anticipated need for continued anticoagulation post-catheterization, including extended bivalirudin infusion.
Any active treatment with oral anticoagulants continued during course of procedure.
Presence of arteriovenous dialysis fistula in the ipsilateral arm.
Any physical deformity or trauma / injury of either wrist that would prevent proper placement or function of the hemostasis band.
Raynaud's syndrome or known peripheral vascular disease of the forearm.
Inability of the patient to personally consent for the study. (no surrogate consent)
History or presence of Radial Artery Occlusion.
Barbeau test showing Pattern D.
Cardiogenic shock or any clinical instability as assessed by the physician performing the procedure.

Primary Outcome Measures

Name	Time	Method
Time to Hemostasis Using the Hemostasis Management System (HMS)	Within 30 minutes of discharge or 24 hours post procedure (± 1 hour), whichever occurs first.	Time to deflation for removal of the TR Band (or TR Band and Statseal) for each group was measured in minutes.

Secondary Outcome Measures

Name	Time	Method
Percent of Patients With Radial Artery Occlusion (RAO)	Within 30 minutes of discharge or 24 hours post procedure (± 1 hour), whichever occurs first.	Radial artery occlusion was monitored for all participants using Barbeau's test and pulse oximetry.

Locations (1): Veteran Affairs Long Beach
🇺🇸
Long Beach, California, United States
Veteran Affairs Long Beach
🇺🇸Long Beach, California, United States